Tag Archives: clinical trials
A tale of two awardees
In many respects Krishna Ella and Elon Musk are poles apart but on some they share a few similarities. Both of them have played along with nationalist elements in their respective national governments in order to further their agendas, if … Continue reading
Posted in Op-eds, Science
Tagged Bharat Biotech, clinical trials, Covaxin, Donald Trump, Dorothy Bishop, Drug Controller General of India, Elon Musk, Indian National Science Academy, Krishna Ella, Narendra Modi, Royal Society
Comments Off on A tale of two awardees
The biopolitics of Covaxin
In a new investigation, STAT has reported fresh problems with Covaxin’s approval process in India, including the phase 2 trial dropping its placebo arm in favour of one preordained to make Covaxin look good and Bharat Biotech – the maker – … Continue reading
Posted in Analysis, Op-eds, Science
Tagged Balram Bhargava, Bharat Biotech, biopolitics, CDSCO, clinical trials, Covaxin, Giorgio Agamben, ICMR, Krishna Mohan
Comments Off on The biopolitics of Covaxin
The toxic affair between Covaxin and The Lancet
That Covaxin has been leading a ceaselessly beleaguered life is no mystery – but The Lancet journal may not know that it has been pressed into the questionable service of saving the vaccine’s reputation on at least three occasions. In … Continue reading
Posted in Analysis, Science
Tagged Bharat Biotech, clinical trials, Covaxin, JAMA, New England Journal of Medicine, retraction index, scientific publishing, The Lancet
Comments Off on The toxic affair between Covaxin and The Lancet
Is Covaxin’s WHO approval guaranteed?
I suspect after reading this PTI report that the WHO is practically helping Bharat Biotech put together a better application to have its COVID-19 vaccine, Covaxin, get the body’s approval for international use, instead of simply considering what Bharat Biotech … Continue reading
Posted in Analysis, Science
Tagged Balram Bhargava, Bharat Biotech, clinical trials, COVAX, Covaxin, Drug Controller General of India, Indian Council of Medical Research, World Health Organization
Comments Off on Is Covaxin’s WHO approval guaranteed?
It’s great that the WHO isn’t just ‘not cutting corners’
Call me anti-national (and I’m sure many will) but I’m glad that the WHO isn’t just “not cutting corners” in the process of considering Bharat Biotech’s application for the UN body’s stamp of approval Covaxin but is also openly calling … Continue reading
Posted in Analysis
Tagged Bharat Biotech, Central Drug Standards Control Organisation, clinical trials, Covaxin, Drug Controller General of India, Prime Minister Narendra Modi, Soumya Swaminathan
Comments Off on It’s great that the WHO isn’t just ‘not cutting corners’
Pandemic: A world-building exercise
First, there was light news of a vaccine against COVID-19 nearing the end of its phase 3 clinical trials with very promising results, accompanied with breezy speculations (often tied to the stock prices of a certain drug-maker) about how it’s … Continue reading
Posted in Op-eds
Tagged anti-vaxxer, clinical trials, COVID-19, COVID-19 vaccine, Donald Trump, epidemiological modelling, epidemiology, healthcare privatisation, migrant workers, phase 3 clinical trials, Politically Math, private healthcare
Comments Off on Pandemic: A world-building exercise